BGN4® / BORI®
B. bifidum / B. longum
Origin：Korea
Patent：Korea and USA
B. bifidum-BGN4® and B.longum -BORI® are discovered by Dr. Geun-Eog Ji, a professor at Seoul National University and a world leading specialist in the research of probiotics. Patented BGN4® has anti -allergy, anti-tumor, anti-infection and bowl regulation effects with strong scientific evidences. Patented BORI® has unique property on inhibiting rotavirus as well as other intestinal infections.
Various Probiotics
Origin：Korea
BIFIDO fully utilize science in nutritious and functional food materials for the improvement of human health and well-being. Focusing on basic research and product development using probiotics, nowadays BIFIDO’s Bifidobacterum and other lactic acid bacteria are being applied widely in functioal foods. Especially, we are in the leading edge in the development of human - health promoting Bifidobacterium.
SPOROS®
L. sporogenes
Origin：Japan
SPOROS® is Lactobacillus sporogenes, more correctly called Bacillus coagulans, a lactic-acid producing bacteria that is generally recognized as a probiotic.SPOROS® does exhibit traits that are advantageous over other Lactobacilli, including the commonly used Lactobacillus acidophilus. It can tolerate higher temperatures, which makes manufacturing easier and cheaper. It also prolongs the shelf life of the supplements. L. sporogenes also tolerate the acidity of the gastric system.
HU58TM
Bacillus subtilis
Origin：India
HU58™ is a bacterial spore of the Bacillus subtilis strain isolated from the human intestinal tract of healthy volunteers. The product has been well studied and is manufatured under license from Royal Holloway College of the University of London ( RHUL ). Indications for use include gut health, antibiotic-induced diarrhea, ulcerative colitis, bacterial vaginosis, urinary tract infection ( UTI ) , and candida vaginal infections. Moreover, HU58™ has been shown in studies to have superior sporulation and germination efficiency. It is stable at extreme pH levels and high temperatures, as well as challenging storage / manufacturing conditions .
Clostridium butyricum M588
Origin：Japan
Clostridium butyricum is a butyric acid bacterium, can produce endospores, which is a key characteristic related to its ability to survive at lower pH and relatively higher bile concentrations. It promotes the growth of Lactobacillus and Bifidobacterium and inhibits antibiotic-associated diarrhea. Oral administration of C. butyricum M588 strain may enhance immunity in the respiratory organs.
SB-55®
S. cerevisiae (boulardii)
Origin：Switzerland
The only yeast that can be recognized as probiotics, SB-55® is a unique Saccharomyces cerevisiae, There are numerous studies showing the efficacy of S. cerevisiae SB-55 in the treatment and prevention of gastrointestinal disorders including acute diarrhea, irritable bowel syndrome ( IBS ), recurrent Clostridium difficile infection, inflammatory bowel disease, antibiotic-associated diarrhea and so on.
